Strides Pharma Science Ltd STAR
NSE · India · Health Technology
INR 1,084.80-35.20 (-3.14%)
Market closed· · INR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · INR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Strides Pharma Science Ltd (BOM:532531) posts strong Q1 FY27 results with 17% ex-US growth and 57% PAT jump, while navigating US market softness and geopolitical headwinds.
Strides Pharma Science Ltd (BOM:532531) reports robust revenue growth and strategic investments, despite challenges in the US market.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.